KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Operating Leases: 2019-2024

Historic Operating Leases for Idexx Laboratories (IDXX) over the last 6 years, with Dec 2024 value amounting to $97.8 million.

  • Idexx Laboratories' Operating Leases rose 7.04% to $133.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.1 million, marking a year-over-year increase of 7.04%. This contributed to the annual value of $97.8 million for FY2024, which is 1.84% down from last year.
  • Latest data reveals that Idexx Laboratories reported Operating Leases of $97.8 million as of FY2024, which was down 1.84% from $99.7 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Operating Leases peaked at $101.2 million during FY2022, and registered a low of $77.0 million during FY2020.
  • Its 3-year average for Operating Leases is $99.6 million, with a median of $99.7 million in 2023.
  • In the last 5 years, Idexx Laboratories' Operating Leases rose by 15.86% in 2022 and then dropped by 1.84% in 2024.
  • Idexx Laboratories' Operating Leases (Yearly) stood at $77.0 million in 2020, then grew by 13.42% to $87.4 million in 2021, then increased by 15.86% to $101.2 million in 2022, then fell by 1.55% to $99.7 million in 2023, then decreased by 1.84% to $97.8 million in 2024.